Amir Hossein ABEDI
(Erciyes Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Kayseri, Türkiye)
Eray EROĞLU
(Erciyes Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Kayseri, Türkiye)
İsmail KOÇYİĞİT
(Erciyes Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Kayseri, Türkiye)
Aydın ÜNAL
(Erciyes Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Kayseri, Türkiye)
Murat Hayri SİPAHİOĞLU
(Erciyes Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Kayseri, Türkiye)
Bülent TOKGÖZ
(Erciyes Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Kayseri, Türkiye)
Oktay OYMAK
(Erciyes Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Kayseri, Türkiye)
Yıl: 2019Cilt: 28Sayı: 1ISSN: 1300-7718 / 2667-4440Sayfa Aralığı: 81 - 83İngilizce

26 0
Colchicine-and Clarithromycin-Induced Rhabdomyolysis in a Hemodialysis Patient with Familial Mediterranean Fever
Familial Mediterranean fever (FMF) is an autosomal recessive hereditary disease characterized by recurrent attacks of fever, usually accompanied by sterile polyserositis. Although colchicine is the main medical treatment option for FMF, potential adverse effects and drug interactions should be considered during the follow-up of these patients. Herein, we presented a case of a hemodialysis patient with FMF, who developed rhabdomyolysis due to concomitant use of colchicine and clarithromycin for pneumonia treatment.
Dergititle.paper.fact_presentationErişime Açık
  • 1. Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum 2009; 61: 1447-53. [CrossRef]
  • 2. Cocco G, Chu DC, Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med 2010; 21: 503-8. [CrossRef]
  • 3. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001-5. [CrossRef]
  • 4. Tateishi T, Soucek P, Caraco Y, Guengerich FP, Wood AJ. Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol 1997; 53: 111-6. [CrossRef]
  • 5. Çelebi ZK, Akturk S, Oktay EI, Duman N, Keven K. Colchicine-induced rhabdomyolysis following a concomitant use of clarithromycin in a haemodialysis patient with familial Mediterranean fever. Clin Kidney J 2013; 6: 665-6. [CrossRef]
  • 6. Rollot F, Pajot O, Chauvelot-Moachon L, Nazal EM, Kélaïdi C, Blanche P. Acute colchicine intoxication during clarithromycin administration. Ann Pharmacother 2004; 38: 2074-7. [CrossRef]
  • 7. van der Velden W, Huussen J, Ter Laak H, de Sévaux R. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. Neth J Med 2008; 66: 204-6.
  • 8. Wilbur K, Makowsky M. Colchicine myotoxicity: case reports and literature review. Pharmacotherapy 2004; 24: 1784-92. [CrossRef]
  • 9. Cohen O, Locketz G, Hershko AY, Gorshtein A, Levy Y. Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori. Rheumatol Int 2015; 35: 1937-41. [CrossRef]
  • 10. Hung IF, Wu AK, Cheng VC, Tang BS, To KW, Yeung CK, et al. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis 2005; 41: 291-300. [CrossRef]
  • 11. Kato K, Iwasaki Y, Onodera K, Higuchi M, Kato K, Kato Y, et al. Pregabalin- and azithromycin-induced rhabdomyolysis with purpura: An unrecognized interaction: A case report. Int J Surg Case Rep 2016; 26: 221-3. [CrossRef]
  • 12. Kaufman MB, Choy M. Pregabalin and simvastatin: first report of a case of rhabdomyolysis. PT 2012; 37: 579-95.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.